These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33606875)

  • 1. Failed Eradication Therapy of New-Onset Pseudomonas aeruginosa Infections in Children With Cystic Fibrosis Is Associated With Bacterial Resistance to Neutrophil Functions.
    Kwong K; Benedetti A; Yau Y; Waters V; Nguyen D
    J Infect Dis; 2022 Jun; 225(11):1886-1895. PubMed ID: 33606875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis.
    Vidya P; Smith L; Beaudoin T; Yau YC; Clark S; Coburn B; Guttman DS; Hwang DM; Waters V
    Eur J Clin Microbiol Infect Dis; 2016 Jan; 35(1):67-74. PubMed ID: 26492874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
    Law JP; Wood AJ; Friman VP
    Microbiol Spectr; 2022 Dec; 10(6):e0184222. PubMed ID: 36453898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
    Mayer-Hamblett N; Kronmal RA; Gibson RL; Rosenfeld M; Retsch-Bogart G; Treggiari MM; Burns JL; Khan U; Ramsey BW;
    Pediatr Pulmonol; 2012 Feb; 47(2):125-34. PubMed ID: 21830317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis.
    Morris AJ; Yau YCW; Park S; Eisha S; McDonald N; Parsek MR; Howell PL; Hoffman LR; Nguyen D; DiGiandomenico A; Rooney AM; Coburn B; Grana-Miraglia L; Wang P; Guttman DS; Wozniak DJ; Waters VJ
    Sci Rep; 2022 Dec; 12(1):21444. PubMed ID: 36509824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment.
    Blanchard AC; Rooney AM; Yau Y; Zhang Y; Stapleton PJ; Horton E; Klingel M; Stanojevic S; Ratjen F; Coburn B; Waters V
    J Cyst Fibros; 2018 Nov; 17(6):723-728. PubMed ID: 29525410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis.
    Morris AJ; Jackson L; Cw Yau Y; Reichhardt C; Beaudoin T; Uwumarenogie S; Guttman KM; Lynne Howell P; Parsek MR; Hoffman LR; Nguyen D; DiGiandomenico A; Guttman DS; Wozniak DJ; Waters VJ
    NPJ Biofilms Microbiomes; 2021 Aug; 7(1):63. PubMed ID: 34349133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Møller SA; Jensen PØ; Høiby N; Ciofu O; Kragh KN; Bjarnsholt T; Kolpen M
    J Cyst Fibros; 2019 Sep; 18(5):657-664. PubMed ID: 30711384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
    Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
    Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of
    Akkerman-Nijland AM; Yousofi M; Rottier BL; Van der Vaart H; Burgerhof JGM; Frijlink HW; Touw DJ; Koppelman GH; Akkerman OW
    Ther Adv Respir Dis; 2020; 14():1753466620905279. PubMed ID: 32046620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis.
    Mostofian F; Alkadri J; Tang K; Thampi N; Radhakrishnan D
    Int J Infect Dis; 2019 Aug; 85():92-97. PubMed ID: 31132474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
    Mayer-Hamblett N; Rosenfeld M; Treggiari MM; Konstan MW; Retsch-Bogart G; Morgan W; Wagener J; Gibson RL; Khan U; Emerson J; Thompson V; Elkin EP; Ramsey BW; ;
    Pediatr Pulmonol; 2013 Oct; 48(10):943-53. PubMed ID: 23818295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
    Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.